---
title: "Pre-market hot trades in US stocks: Nicola Mining pre-market down 3.92%, high-grade gold mine agreement fails to boost market confidence"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283129266.md"
description: "Nicola Mining pre-market down 3.92%; YXT.COM pre-market up 89.95%; Psyence Biomedical pre-market up 78.88%; Texxon pre-market up 55.59%"
datetime: "2026-04-17T10:37:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283129266.md)
  - [en](https://longbridge.com/en/news/283129266.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283129266.md)
---

# Pre-market hot trades in US stocks: Nicola Mining pre-market down 3.92%, high-grade gold mine agreement fails to boost market confidence

**Pre-market Hot Trades in US Stocks**

Nicola Mining is down 3.92% in pre-market trading. Based on recent key news:

1.  On April 16, Nicola Mining released detailed information about its mining and milling profit-sharing agreement through the EDGAR system. This agreement involves high-grade BC gold mining projects, which could positively impact the company's future profitability, but the market reacted poorly, leading to a decline in stock price.
    
2.  On April 14, Nicola Mining announced that its fully licensed milling facility is capable of processing gold and silver ore and has multiple mineral projects, including New Craigmont and Treasure Mountain. The potential of these projects has not been immediately reflected in the stock price, and the market remains cautious about its long-term development.
    
3.  On April 14, Nicola Mining's announcement mentioned that it owns 100% of the New Craigmont project, which is adjacent to Canada's largest copper mine, Highland Valley Copper, showing significant mineral potential, but failed to boost the stock price. The mining sector has been volatile recently and requires attention.
    

**Top Gainers in Pre-market US Stocks**

YXT.COM is up 89.95% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Psyence Biomedical is up 78.88% in pre-market trading. Based on recent key news:

1.  On April 15, Psyence Biomedical announced a collaboration with experienced hospitals and specialized research partners and is supplying NPX-5 from its GMP-certified facility, aiming to accelerate patient recruitment, improve operational efficiency, and solidify its position in the emerging psychedelic drug clinical field. This news significantly boosted the stock price. Source: Reuters
    
2.  No other significant news recently. The psychedelic drug sector is developing rapidly, and market attention is high.
    

Texxon is up 55.59% in pre-market trading. Based on recent key news:

1.  On April 15, a Form 3 document released by Texxon Holding showed that CEO and Director Hui Xu reported an indirect ownership of 6,656,667 shares of common stock. This information was released through the EDGAR system of the U.S. Securities and Exchange Commission, indicating the confidence of the company's executives in the stock, leading to a significant increase in stock price.
    
2.  On April 15, Texxon Holding's Form 3 document also showed that Chief Technology Officer Jian Huang indirectly holds 2,686,197 shares of common stock through EXCP HJ Holding Limited. This shareholding information was also released through the EDGAR system, further enhancing market confidence in the company's future development and driving the stock price up. The market reacted positively to the executive shareholding information

### Related Stocks

- [NICM.US](https://longbridge.com/en/quote/NICM.US.md)

## Related News & Research

- [Nicola Mining Inc. Engages ICP Securities Inc. for Automated Market Making Services | NICM Stock News](https://longbridge.com/en/news/284263197.md)